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EVIDENCE FOR GRAFT COLONIZATION WITH PERIODONTAL PATHOGENS 
IN LUNG TRANSPLANT RECIPIENTS – A PILOT STUDY 
 
Abstract 
Bronchiolitis obliterans syndrome (BOS) is a major cause of late graft dysfunction in lung 
transplant recipients. There is increasing evidence that beside alloimmunologic injury also 
non-alloimmunologic inflammatory conditions may raise the risk of acute and chronic 
rejection. The oral cavity represents a possible reservoir for pathogenic bacteria due to its 
close anatomical proximity. In this pilot study, the presence of pathogenic periodontal 
bacteria in the oral cavity as well as in the lungs of lung transplant recipients was investigated 
for the first time. 
Eight lung transplant recipients underwent broncho-alveolar lavage, transbronchial biopsies, 
and endobronchial biopsies. In addition to routinely performed examinations, pulmonary as 
well as plaque samples were assessed for Aggregatibacter actinomycetemcomitans (Aa), 
Tannerella forsythia (Tf), Porphyromonas gingivalis (Pg), and Treponema denticola (Td) 
with the aid of a hybridisation technique. 
No or one periodontal pathogen (solitarily Pg) was found in the gingival plaques of five of the 
eight patients (group A). In three patients, two or more periodontal pathogens were 
detetectable in the gingival samples (group B). Whereas group A had also not more than one 
periodontal pathogen in the lungs, group B had more than one species in the lungs. In group 
B, all patients suffered from BOS, whereas in group A only one patient was affected. 
This is the first evidence for the presence of periodontal pathogens in the lungs of lung 
transplant recipients. Further studies with larger cohorts are required to elucidate potential 
links between periodontal infection, pulmonary colonization, and rejection. 
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Zusammenfassung 
Das Bronchiolitis-obliterans-Syndrom (BOS) ist ein verbreiteter Grund für eine späte 
Transplantat-Dysfunktionn bei Lungen-Transplantat-Empfängern. Neben 
alloimmunologischen Prozessen werden neuerdings auch nicht-alloimmunologische 
entzündliche Reaktionen als Risiko für eine akute oder chronische Abstossungsreaktion 
diskutiert. Die Mundhöhle stellt wegen ihrer anatomischen Nähe ein mögliches Reservoir für 
pathogene Keime dar. In dieser Pilot-Studie wurde zum ersten Mal die Anwesenheit von 
parodontal pathogenen Keimen in Taschen sowie in den Lungen von Lungen-Transplantat-
Empfängern untersucht.  
Acht Lungen-Transplantat-Patienten unterzogen sich einer broncho-alveolären Lavage, sowie 
einer trans- und endobronchialen Biopsie. Zusätzlich zu den Routineuntersuchungen wurden 
Lungen- und orale Plaqueproben auf die Anwesenheit von Aggregatibacter 
actinomycetemcomitans (Aa), Tannerella forsythia (Tf), Porphyromonas gingivalis (Pg), und 
Treponema denticola (Td) mit einer DNA-Hybridisierungstechnik untersucht.  
Keine oder ein parodontaler Markerkeim (ausschliesslich Pg) wurden in der Plaqueprobe von 
fünf der acht Patienten gefunden (Gruppe A). Bei den übrigen drei Patienten wurden 2 oder 
mehr Keime festgestellt (group B). Während bei den pulmonalen Proben bei Gruppe A nie 
mehr als einer der Keime festgestellt wurde, zeigte die Patienten in Gruppe B alle mehr als 
eine Spezies. In Gruppe B litten zudem alle Patienten an BOS. In der Gruppe A litt lediglich 1 
Patient darunter. 
Diese Pilotstudie liefert zum ersten Mal Evidenz, dass parodontal pathogene Keime in den 
Lungen von Lungen-Transplantierten Patienten gefunden werden können. Weitere Studien 
mit grösseren Kohorten sind allerdings von Nöten, um die möglichen Zusammenhänge 
zwischen Pardontalerkrankungen, pulmonaler Infektion und Abstossung aufzuzeigen. 
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Résumée 
Le syndrome de la bronchiolite oblitérante (BOS) est une cause fréquente dyfunction greffe 
de retard chez les transplantés pulmonaires. Outre les conditions alloimmunologiques, plus 
récemment, la réaction non-alloimmunologique inflammatoire se produit comme un risque 
pour un rejet aigu ou chronique en question. La cavité buccale est un réservoir potentiel de 
bactéries pathogènes à cause de leur proximité anatomique. Cette étude pilote a étudié pour la 
première fois la présence de germes pathogènes parodontaux dans des poches parodontaux et 
dans les poumons des patients greffés du poumon.  
Huit patients ont subi une greffe de poumon lavage broncho-alvéolaire, et des biopsies trans-
et endobronchique. En plus, des prélèvements de plaque ont été pris concernant le poumon et 
de la plaque oral et la présence de Aggregatibacter  Aggregatibacter (Aa), Tannerella 
forsythia (Tf), Porphyromonas gingivalis (Pg), Treponema denticola (Td) était examiné avec 
une technique d'hybridation de l'ADN.  
Aucun ou seulement une germe pathologique (uniquement Pg) ont été trouvés dans des 
échantillons provenant de cinq patients (groupe A). Concernant les trois autres patients, deux 
ou plusieurs bactéries ont été identifiés (groupe B). Alors que dans le groupe A, jamais plus 
d'une bactérie a été trouvée dans le poumon. Chez les patients de la groupe B, toujours 
plusieurs espèces ont été identifiés. En outre, tous les patients du groupe B avait BOS. Dans le 
groupe A un seul patient en a souffert.  
Cette étude pilote démontrait pour la première fois que les bactéries parodontales peuvent être 
trouvées dans les poumons des patients greffés du poumon. D'autres études avec de plus 
grandes cohortes sont néanmoins nécessaires pour démontrer la potentielle relation entre des 
maladies parodontaux, les infections pulmonaires et la réaction de rejet. 
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Introduction 
Bronchiolitis obliterans (BO) and its clinical correlate bronchiolitis obliterans syndrome 
(BOS) is the major cause of late graft dysfunction in lung transplant recipients affecting up to 
50-60% of patients who survive after surgery (GLANVILLE et al. 1987). Although BOS is 
thought to be mediated by an allo-immunologic injury, it is likely that non-allo-immunologic 
inflammatory conditions also play a role. Bacterial, viral and fungal infections may increase 
the risk of acute rejection (GIRGIS et al. 1996) and, in some centers, it has been shown that 
cytomegalovirus infection was associated with chronic rejection (KROSHUS et al. 1997). 
However, despite high clinical suspicion, data dealing with the impact of infection as risk 
factor for BOS is scarce.  
Periodontitis, a local inflammation in the supporting tissues of the teeth, is thought to be the 
result of a disruption of the homeostatic balance between the host response and pathogenic 
microorganisms (HAFFAJEE et al. 1991). Prevalence and proportions of periodontal bacteria 
vary among patients with periodontitis and control subjects (VAN WINKELHOFF et al. 2002). 
Aggregatibacter actinomycetemcomitans (Aa), Tannerella forsythia (Tf, former Bacteroides 
forsythus), Porphyromonas gingivalis (Pg), and Treponema denticola (Td) have been shown 
to be strongly associated with destructive periodontal infections. 
The oral cavity has long been considered a potential reservoir for respiratory pathogens; both, 
colonization of dental plaques with respiratory pathogens (SCANNAPIECO et al. 1992) and lung 
infection by periodontal flora (MORRIS & SEWELL 1994, TAYLOR et al. 2000) are well known. 
Furthermore, chronic oral infections have been reported to be associated with systemic 
diseases including myocardial infarction and stroke. DNA from different periodontal 
pathogens has been found in atheromatous plaques of carotids (HARASZTHY et al. 2000). 
These disorders seem to be linked by the interaction between bacteria and their products and 
the intensity of the host inflammatory response. 
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To date, it is not known, whether periodontal pathogens can be found in transplanted human 
lungs and whether the severity of transmission is associated with clinical complications. In 
this pilot study we investigated the presence or absence of putative periodontopathogenic 
bacteria  in the oral cavity as well as the lungs of 8 lung transplant recipients.  
 
 
Materials and Methods 
This pilot study was approved by the local ethics committee (EK 1164, 24.1.2005). All 
patients gave written informed consent.  
In our program surveillance bronchoscopies are performed on a monthly basis during the first 
six months after transplantation. Indication bronchoscopies are performed whenever clinically 
indicated, usually due to deterioration of lung function. In the current study eight 
chronologically sequential lung transplant recipients who were off antibiotic treatment for at 
least two weeks and were scheduled for either routine surveillance bronchoscopy or clinically 
indicated bronchoscopy underwent broncho-alveolar lavage, transbronchial biopsies, and 
endobronchial biopsies. Samples were routinely sent for microbiology, differential cell counts 
and histology. Routine microbiological analyses for broncho-alveolar lavage samples were 
performed using blood agar and macconkey agar. Oral flora was defined as a typical mixed 
flora. Rejection of the lung was graded according to the International Society for Heart and 
Lung Transplantation (ISHLT) Working Formulation (YOUSEM et al. 1996). With this system 
perivascular as well as periobronchiolar lymphocyte infiltration (for acute rejection) and 
bronchiolar obliteration (for chronic rejection) are described in a standardized fashion. In all 
patients, lung function tests were performed prior to bronchoscopy. The term BOS was used 
in accordance with the new Working Formulation of the ISHLT (ESTENNE et al. 2002). 
We wanted to circumvent any antibiotic treatment before the bronchoscopy was performed 
due to impaired bacteriologic yield of the transplanted lung under antibiotic treatment. On the 
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other hand, due to the immunosuppressive regimen immediate antibiotic prophylaxis before 
periodontal probing is standard care in our transplant program requiring subgingival 
manipulations. Hence, due to this severe status of immunosuppression of these patients, any 
generalized gingival manipulation was avoided as consequently as possible Therefore, it was 
not possible to chart the periodontal probing pocket depths before the sampling procedures in 
order to choose appropriate sites. To meet these concerns, a standardized simplified and 
minimal-invasive sampling protocol was used and supra- and subgingival plaque was 
collected and only one site was manipulated: A paper point was used to collect a combined 
supra- and subgingival plaque at the mesial surface of the first lower right molar (if not 
existing of the nearest available tooth mesially) for ten seconds and placed into a stabilizing 
guanidinium-buffer two hours before bronchoscopy. 
The endobronchial biopsy sample was obtained from the upper lobe carina, one transbronchial 
biopsy sample and 1ml of broncho-alveolar lavage fluid were also transferred to guanidinium-
buffer. Then, hybridisation was done. The probes that were used are synthetic DNA 
oligonucleotide probes directed against the small subunit ribosomal RNA (SSU rRNA) of 
four of the most pathogenic periodontic bacteria namely Aggregatibacter 
actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, and Treponema 
denticola (IAI PadoTest4.5®). This test avoids amplification steps in order to facilitate exact 
quantification. Unlike polymerase chain reaction based approaches the hybridisation 
technique used in this study allows a quantitative assessment of different bacterial species. 
Quantification is performed by using plasmid-cloned copies of the ribosomal RNA gene of 
each tested species. After hybridisation with the probe, the samples are compared to the 
standard and the bacterial number is computed by assuming that 10’000 ribosomal RNA 
copies are equivalent to one bacterium. Furthermore, the total bacterial load of the sample was 
determined by a universal probe. The quantitative results of the DNA-rRNA hybridisation are 
given as proportion of the determined species compared to the total bacterial load. 
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From lung specimens, the sample with the highest number of pathogenic species detected was 
taken into consideration. Subjects were further evaluated depending on the number of these 
pathogens found in their gingival samples. Based on the latter findings, we arbitrarily defined 
a group A, where only one or none of the four marker bacteria was identified in the oral 
cavity, whereas patients were attributed to a group B, which was defined by the detection of 
two or more species in the oral sample. 
 
 
Results 
Eight bilaterally lung transplanted patients underwent fibreoptic bronchoscopy either for 
routine surveillance (5 patients, 63%) or for diagnostic work up (3 patients, 37%). The 
clinical characteristics of these patients and the results of the bacterial examination are shown 
in Table 1. 
In five of the eight patients one or less of the four above mentioned periodontal pathogens 
was found in the gingival plaque (group A), the other patients had two or more of the 
periodontal pathogens (group B). In two of these three patients all bacteria were also detected 
in the transplanted lungs, whereas patients harboring only one of these periodontal bacteria in 
the gingival collecting area had also not more than one pathogen in the lungs.  
Figure 1 shows the fraction of each of the four bacterial species (expressed as percentage of 
the total bacterial load) of both groups in the gingiva and in the lungs, respectively. 
In the pulmonary compartment of the three patients of group B the extent of bacterial 
colonization varied between broncho-alveolar lavage, endobronchial and transbronchial 
biopsies. In one patient, dental pathogen species were exclusively found in the transbronchial 
biopsy specimen. In the other two patients, the pathogens were found in three and two lung 
specimens, respectively. 
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The cytology of the broncho-alveolar lavage, the histology of the transbronchial biopsy and 
the sum of the dental pathogens of the two groups are shown in Table 2 (as medians with 
interquartile ranges, % for categoric items). By conventional culture techniques, 
representatives of an oral flora were found in the broncho-alveolar lavage in one patient of 
each group (Table 2). 
One patient in group A fulfilled the clinical criteria for BOS, whereas every patient in group B 
at least suffered from BOS stage 0-p (Table 1). 
 
 
Discussion 
The risk of infection after lung transplantation is considerably higher as compared to other 
solid organ transplant recipients and more than 70% of infections involve the respiratory tract 
(KRAMER et al. 1993). Whereas bacterial bronchopneumonia caused by Gram-negative 
species is a well described entity (SPEICH & VAN DER BIJ 2001) little is known about 
colonization or infection of the transplanted lung with the host’s dental flora. Using DNA 
probes directed against SSU rRNA of selected dental pathogenic species (Aggregatibacter 
actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis, and Treponema 
denticola) we identified these bacteria not only in the supra- and subgingival biofilm of lung 
transplant recipients but also in their lungs. Since RNA's are quickly degraded once the 
bacteria are removed from their natural medium, these molecules are particularly suitable for 
detection of vital microorganisms. We have demonstrated that pathogenic gingival microflora 
can also be found in the transplanted lung. We feel that these findings are remarkable. With 
conventional culture techniques dental pathogens are often underestimated due to their 
anaerobic growth and not differentiated but only mentioned as “oral flora” and unappreciated 
as putative contaminants of bronchoalveolar lavage. In our study, only in one patient of each 
group microbiological results were reported as “oral flora”. In one of the three patients with 
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lungs positive for more than one pathogen exclusively the transbronchial biopsy specimen 
was positive. This makes simple contamination unlikely and argues for colonization or 
infection. A further argument against contamination is the fact that in all but one case (Case 
No2) endoscopy was performed through the nasal route. Most of all, the hybridisation 
technique which we have used in the current study strongly argues against a simple 
contamination of the endoscope and other instruments. 
All patients with ≥ 2 pathogens in the gingival plaque (arbitrarily referred as group B) met the 
criteria for BOS (at least stage 0-p) whereas only one of five patients of group A did. Because 
of the small number of patients no statistical comparison could be made but an association 
between pulmonary colonization or infection with pathogenic gingival flora and BOS is 
conceivable. Primary infection with consecutive BO or secondary colonization in a lung with 
preexistent BO are both possible scenaria. The latter is a well known phenomenon probably 
due to architectural damage and over-immunosuppression. Since periodontal disease and BO 
share some phenomenological aspects (i.e. inadequate inflammatory responses to different 
injuries and a specific individual genetic predisposition) the first hypothesis (pulmonary 
infection with dental pathogens leading to BO) needs further attention. Considering the 
significance of the clinical problem additional studies are highly warranted and like in many 
other fields an interdisciplinary approach seems ideal and promising.  
One critical point of this study is the simplified oral detection method of bacteria. Under 
normal conditions, selection of the deepest pocket in each quadrant has been shown to be the 
most efficient method of sampling (MOMBELLI et al. 1991a). However, due to the severe 
status of immunosuppression of these patients, any additional gingival manipulation was 
avoided under stringent conditions as suggested by the internal clinical guidelines and the 
ethical protocol for safety reasons, despite a lack of evidence concerning lung transplant 
patients. Taking these concerns into consideration, only one site was scheduled for epi- and 
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subgingival manipulation. In addition, given the potentially high number of samples needed to 
reliably detect the presence of P. gingivalis and other oral pathogens, the simple method of 
collecting supra- and subgingivally at only one specific site, presented an inferior, but 
adequate solution for screening the patient in a standardized manner. MOMBELLI and co-
workers (1991) found that in patients with moderate to advanced chronic periodontitis three 
distinct patterns of distribution and relative proportion of P. gingivalis were recognized. In 
one group of patients, the organism was not cultured. In a second group, few positive sites 
with low proportions of P. gingivalis were present. A third group of patients yielded high 
frequencies and proportions of P. gingivalis. Sampling of only one site could potentially lead 
to inadequate or underestimation of the bacteria found in the sample. However, it was shown 
that in the molar region, frequencies and mean proportions of P. gingivalis increased, which 
makes this area a potentially appropriate site (MOMBELLI et al. 1991b). Due to uneven and 
even cluster like distribution of positive samples in certain areas of the dentition, potential 
difficulties even remain when sampling more than one site. In this study, seven of the eight 
patients revealed P. gingivalis in the oral samples, which is a high frequency given the 
limitation of just one arbitrary sample site. On the other hand, one can speculate that a 
prevalence of a ≥2 bacteria in a single site may argue for a increased contamination potential 
of the whole oral cavity and therefore a higher overall oral and gingival contamination, which 
may more easily spread in the body. Therefore that arbitrary allocation to a „high“ (≥ 2 
bacteria) and „low“ colonization group may be justified and explain our preliminary, but 
clinically relevant findings in the lung parenchyma. 
Despite this particular shortcoming of this pilot and feasibility study, the presented findings 
and results are the first to show that pathogenic oral bacteria can be detected in the lung 
parenchyma of lung transplant recipients, irrespective of the arbitrary colonization type 
pattern in the oral cavity.  
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Other limitations of this study lay in its cross sectional nature and in the small number of 
study patients included. Furthermore, the frequent use of antibiotics in this population 
hampers diagnostic approaches to a certain degree. Since antibiotic treatments are necessary 
so frequently in lung transplant recipients a maximum time period off antibiotics of only two 
weeks could be applied.  
However, if these results are confirmed in larger studies they may well lead to new diagnostic 
and treatment strategies for better allograft survival. 
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Figure legends 
 
Figure 1.  Proportion of the four determined pathogen species (Aa, Tf, Pg and Td, see text) 
expressed as percentage of total bacterial load from gingival (left column) and pulmonary 
(BAL, EBB or TBB, the specimen with the highest bacterial load was chosen; right column) 
specimen. Group A (defined as having one or less of the four species in the gingival biofilm) 
is shown in the upper panel, group B (two or more) in the lower panel. 
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Figure 1 
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Tables 
 
Table 1 Clinical characteristics and periodontal pathogens 
 
Patient 
nummber 
Underlying 
disease 
Age 
at 
TX 
m/f 
Time 
since Tx 
(Months) 
Current 
Lung 
volumen 
(FEV1% 
baseline) 
Fuctional 
signs of 
chronic 
Rejection 
Bronchoscopy 
surveillance / 
diagnostic 
Rejection 
(biopsy 
grading 
according 
ISHLT) 
Microbio-
logical 
findings 
(BAL) 
Presence of 
periodontal 
pathogens 
at gingival 
sites 
Presence of 
periodontal 
pathogens in 
allograft 
1 PPH 51/f 7 93 no s A1B0 - Pg Tf 
2 CF 34/f 46 58 no d A2Bx Oral flora - Tf 
3 Emphysema 43/m 15 75 no d AxBx - Pg Pg 
4 IPF 48/m 4 100 no s A0B0 - Pg Td 
5 Emphysema 52/m 65 52 yes d Ax(2)Bx(0) Staph. aureus Pg Td 
6 Emphysema 55/m 35 81 yes d A0B0 - Aa, Tf, Pg, Td 
Aa, Tf, Pg 
(BAL, TBB, 
EBB) 
7 Emphysema 44/m 54 74 yes d A2BxC Oral flora Aa, Tf, Pg, Td 
Aa, Tf, Td 
(TBB) 
8 Emphysema 48/f 4 85 yes s A1B0 Anaerobic flora Aa, Pg, Td 
Pg,Td 
(BAL, TBB) 
 
 
 
 
 
 
 
 
 
PPH=primary pulmonary hypertension; CF=cystic fibrosis; IPF=idiopathic pulmonary fibrosis; FEV1=forced expiratory lung 
volume in one second, ISHLT=International Society for Heart and Lung Transplantation; BAL=bronchoalveolar lavage; 
TBB=transbronchial biopsy; EBB=endobronchial biopsy; Aa= Aggregatibacter actinomycetemcomitans; Tf=Tannerella forsythia; 
Pg=Porphyromonas gingivalis; Td=Treponema denticola. x=less than five histological evaluable fragments. *persistent after 
treatment of acute rejection. 
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Table 2  Bronchoscopic and microbiological findings  
 
   
Group A (n=5) 
(one or less 
periodontal 
pathogen 
gingival) 
Group B (n=3) 
(two or more 
periodontal 
pathogens 
gingival)  
 BAL   
   BAL total cell count (103/ul) 200 (200) 200 (200-300) 
   BAL neutrophils (%) 2 (1-35) 12 (2-16) 
   BAL lymphocytes (%) 8 (2-8) 4 (0-5) 
   microbiological findings    
     oral flora 1 (20%) 1 (33%) 
     others 1 (20%) 1 (33%) 
 TBB    
   ISHLT A0 1 (20%) 1 (33%) 
   ISHLT other 4 (80%) 2 (66%) 
 In situ hybridisation*    
   gingival 2.8 (0.6-3) 17.3 (4.3-38.5) 
   pulmonary** 0.8 (0.5-1) 11.7 (5.8-22.6) 
 
 
 
 
 
 
 
Values are number (%) for categoric items or median (lower and upper quartile) for 
numerical items. BAL=bronchoalveolar lavage; TBB=transbronchial biopsy; 
ISHLT=International Society for Heart Lung Transplantation. 
*means the sum of the four determined pathogen species (Aa, Tf, Pg and Td, see 
text), expressed as the percentage of total bacterial load 
**pulmonary sample with the highest number of pathogens was taken into consideration 
 
